Stable transduction of breast cancer cell lines with EpCAM-specific lentiviral shRNA constructs results in more than 90% reduction in EpCAM protein expression as measured by immunoblot (Figure 1a). The gene discussed is EPCAM; the disease is breast carcinoma.